[Skip to Navigation]
October 1989

Prostatic Complications of Testosterone Replacement Therapy

Author Affiliations

From the Departments of Medicine (Dr Jackson), Surgery (Dr Waxman), and Pathology (Dr Spiekerman), Scott and White Clinic, Scott and White Memorial Hospital, Scott, Sherwood and Brindley Foundation, Texas A&M University College of Medicine, Temple.

Arch Intern Med. 1989;149(10):2365-2366. doi:10.1001/archinte.1989.00390100157033

• The prostatic complications of testosterone replacement therapy have received little clinical attention. We describe three hypogonadal men who had prostatic disease (adenocarcinoma in two) detected in relation to such therapy. Literature review suggests that surveillance for early prostate cancer is appropriate during replacement therapy in men over the age of 50 years. We discuss the selective use of digital rectal examination, transrectal sonography, directed prostate biopsy, and prostate-specific antigen determinations before therapy and in subsequent follow-up in this age group of men during androgen replacement.

(Arch Intern Med. 1989;149:2365-2366)

Add or change institution